Laboratorio del Fin del Mundo and OSEF visit Montpellier plant

Officials from Laboratorio del Fin del Mundo and OSEF recently visited the Laboratorio Montpellier production plant in the Villa Lugano neighborhood of Buenos Aires to discuss pharmaceutical advancements and new therapeutic alternatives for rheumatological diseases.

During the visit, Cecilia Rojo, Vice President of Laboratorio del Fin del Mundo, and Gustavo García, President of OSEF, met with company executives and attended a technical lecture on industry trends and treatment innovations. A primary focus of the meeting was the presentation of Bimzelx (bimekizumab), a therapeutic alternative recently introduced to the Argentine market for treating psoriatic arthritis and axial spondyloarthritis.

Rojo emphasized the necessity of dialogue between public institutions and pharmaceutical companies to drive strategic health solutions. García noted that gaining insight into innovative molecules like bimekizumab provides essential tools for planning accessible and modern healthcare coverage for OSEF affiliates.